- United States
- /
- Healthcare Services
- /
- NasdaqCM:VMD
3 US Growth Stocks With Insider Ownership Up To 31%
Reviewed by Simply Wall St
As the U.S. stock market experiences a mixed performance with the S&P 500 and Dow Jones Industrial Average ending their six-week winning streaks, investors are keenly observing economic data and corporate earnings for signs of stability. In this environment, growth companies with substantial insider ownership can be particularly appealing, as such ownership often indicates confidence in the company's long-term prospects by those closest to its operations.
Top 10 Growth Companies With High Insider Ownership In The United States
Name | Insider Ownership | Earnings Growth |
Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 23.4% |
GigaCloud Technology (NasdaqGM:GCT) | 25.6% | 26% |
Victory Capital Holdings (NasdaqGS:VCTR) | 10.2% | 33.3% |
Super Micro Computer (NasdaqGS:SMCI) | 25.7% | 28.7% |
Hims & Hers Health (NYSE:HIMS) | 13.7% | 37.4% |
Duolingo (NasdaqGS:DUOL) | 14.7% | 41.7% |
Bridge Investment Group Holdings (NYSE:BRDG) | 11.3% | 102.3% |
Credo Technology Group Holding (NasdaqGS:CRDO) | 13.9% | 95% |
EHang Holdings (NasdaqGM:EH) | 32.8% | 81.4% |
BBB Foods (NYSE:TBBB) | 22.9% | 51.2% |
We'll examine a selection from our screener results.
Viemed Healthcare (NasdaqCM:VMD)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Viemed Healthcare, Inc. provides home medical equipment and post-acute respiratory healthcare services in the United States, with a market cap of approximately $358.75 million.
Operations: The company generates revenue from its Sleep and Respiratory Disorders Sector, amounting to $205.70 million.
Insider Ownership: 12.7%
Viemed Healthcare's insider ownership aligns with its growth trajectory, as earnings are forecast to grow significantly at 32.5% annually, outpacing the US market. Despite a slower revenue growth rate of 11.8%, it still surpasses the market average. Recent earnings showed a sales increase to US$54.97 million, although net income declined year-over-year. A shelf registration for US$56.63 million suggests potential capital raising activities, reflecting strategic positioning amidst anticipated growth challenges and opportunities.
- Take a closer look at Viemed Healthcare's potential here in our earnings growth report.
- Our comprehensive valuation report raises the possibility that Viemed Healthcare is priced higher than what may be justified by its financials.
Capital Bancorp (NasdaqGS:CBNK)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Capital Bancorp, Inc. is the bank holding company for Capital Bank, N.A., with a market cap of $395.80 million.
Operations: The company's revenue segments are comprised of Opensky at $70.71 million, Corporate at $2.74 million, Commercial Bank at $78.21 million, and Capital Bank Home Loans (CBHL) at $5.84 million.
Insider Ownership: 31.1%
Capital Bancorp shows strong growth potential with earnings expected to grow significantly at 29.6% annually, surpassing the US market average. Insider confidence is evident with substantial insider buying over the past three months and no significant selling. Despite a low forecasted return on equity of 14.1%, revenue growth is anticipated to exceed market rates at 20.6% annually. Recent board changes include Marc McConnell's appointment, enhancing leadership amid strategic expansions following a merger completion.
- Click here to discover the nuances of Capital Bancorp with our detailed analytical future growth report.
- Our expertly prepared valuation report Capital Bancorp implies its share price may be lower than expected.
TXO Partners (NYSE:TXO)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: TXO Partners, L.P. is an oil and natural gas company engaged in acquiring, developing, optimizing, and exploiting conventional reserves in North America with a market cap of approximately $739.84 million.
Operations: The company's revenue primarily comes from the exploration and production of oil, natural gas, and natural gas liquids, totaling $286.59 million.
Insider Ownership: 25.2%
TXO Partners demonstrates potential for growth with earnings forecasted to increase significantly by 156.86% annually, although its revenue growth rate of 18.5% is slower than the desired threshold but still above the US market average. Despite trading significantly below estimated fair value, recent financials show mixed results with a net income turnaround in Q2 but a substantial decline over six months. The dividend yield of 10.8% remains unsustainable due to insufficient earnings coverage.
- Click here and access our complete growth analysis report to understand the dynamics of TXO Partners.
- Our valuation report here indicates TXO Partners may be undervalued.
Key Takeaways
- Take a closer look at our Fast Growing US Companies With High Insider Ownership list of 188 companies by clicking here.
- Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
- Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Contemplating Other Strategies?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqCM:VMD
Viemed Healthcare
Provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States.
Flawless balance sheet with reasonable growth potential.